Within the next five years, the global market for psychedelics will reach a value of over $6 billion. According to a new analysis, this indicates a compound annual growth rate of over 16 percent for the industry. According to Data Bridge Market Research, it was valued at more than $2 billion in 2019. In a recent equity sale, Compass Pathways plc raised $144 million. Field Trip Health Ltd. was only three weeks ago listed on the Toronto Stock Exchange. In the biopharma industry, the development of psychedelics as a distinct branch of the health industry has caused a stir. The Johns Hopkins Center for Psychedelic and Consciousness Research, which opened in 2019, has achieved some of the most significant advances in psychedelic research.
Here is Insider Monkey’s list of the 10 best psychedelic companies to watch. On the list of the top ten psychedelic companies to watch, Seelos Therapeutics, Inc. is ranked tenth. Over the last few months, the stock has provided investors with returns of more than 171 percent. SLS-002, one of the company’s key medications for treating depression, is psychedelic-related. On the list of the top ten psychedelic companies to watch, HAVN Life Sciences Inc. is ranked ninth. The company promotes itself as the hallucinogenic medicine of the future. Cordyceps Perform and Mind Mushroom are two of the company’s products. Mind Medicine Inc. is a biotechnology firm that specializes in psychedelic medicine for the treatment of addictions and mental diseases. Over the last year, the company’s stock has provided investors with returns of more than 1,000 percent. Numinus Wellness Inc. is a mental health company that sells psychedelic psychotherapy. Atai Life Sciences N.V. is supported by Peter Thiel, a well-known investor who has sponsored a number of successful technological businesses. For more details, click 10 Best Psychedelic Companies to Watch.
Unsplash
